Suchergebnisse - "Hepatitis B Surface Antigens"

PubPharm (23.483)

1

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection

enthalten in: JHEP reports : innovation in hepatology | 2024

von Wu, J. | Tai, C. | Chang, K. | +5

2

Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets

enthalten in: Journal of ethnopharmacology | 2024

von Ji, L. | Wei, J. | Zhang, R. | +7

3

Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma

enthalten in: Hematological oncology | 2024

von Feng, J. | Fei, Y. | Gao, M. | +10

4

A case-control study of risk factors for incident hepatitis B virus infection in South African blood donors

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Jentsch, U. | Vermeulen, M. | van den Berg, K. | +7

5

Optimizing off-treatment outcome predictions : The potential of time-varying HBcrAg and the need for more research

enthalten in: Clinical and molecular hepatology | 2024

von Tsai, Y. | Wu, J. | Hsu, Y.

6

Interferon-γ+ Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization

enthalten in: Journal of medical virology | 2024

von Wu, L. | Deng, H. | Feng, X. | +12

7

Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients

enthalten in: Virology journal | 2024

von Liu, H. | Chen, S. | Liu, X. | +1

8

Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines

enthalten in: Blood reviews | 2024

von Mikulska, M. | Oltolini, C. | Zappulo, E. | +5

9

CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Lee, H. | Yip, T. | Wong, V. | +5

10

Reply to : "A comment on `A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B'"

enthalten in: Journal of hepatology | 2024

von van Bömmel, F. | Berg, T.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2349]